Thomas Bachleitner‐Hofmann

3.9k total citations · 1 hit paper
86 papers, 2.7k citations indexed

About

Thomas Bachleitner‐Hofmann is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Thomas Bachleitner‐Hofmann has authored 86 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 23 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Thomas Bachleitner‐Hofmann's work include Breast Cancer Treatment Studies (12 papers), Immunotherapy and Immune Responses (11 papers) and Colorectal Cancer Surgical Treatments (9 papers). Thomas Bachleitner‐Hofmann is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Immunotherapy and Immune Responses (11 papers) and Colorectal Cancer Surgical Treatments (9 papers). Thomas Bachleitner‐Hofmann collaborates with scholars based in Austria, United States and Germany. Thomas Bachleitner‐Hofmann's co-authors include Michael Gnant, Dietmar Pils, Agnes T. Reiner, Robert Zeillinger, Nyamdelger Sukhbaatar, Ildikó Mesteri, Anna Bachmayr-Heyda, R. Jakesz, Katharina Auer and Stefanie Aust and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Thomas Bachleitner‐Hofmann

83 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues

2015 603 citations Thomas Bachleitner‐Hofmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Bachleitner‐Hofmann Austria	30	1.3k	1.1k	978	438	381	86	2.7k
Oronzo Brunetti Italy	35	1.1k 0.9×	783 0.7×	1.5k 1.6×	692 1.6×	440 1.2×	126	3.1k
Ricardo R. Lastra United States	21	1.2k 0.9×	781 0.7×	1.1k 1.1×	663 1.5×	355 0.9×	76	3.1k
Xiaoqun Dong United States	34	1.5k 1.2×	998 0.9×	852 0.9×	197 0.4×	374 1.0×	84	2.7k
Ayumu Taguchi United States	30	1.5k 1.2×	881 0.8×	884 0.9×	329 0.8×	518 1.4×	62	2.8k
Rachel Midgley United Kingdom	26	929 0.7×	559 0.5×	1.7k 1.7×	349 0.8×	288 0.8×	56	2.8k
Hiroko Bando Japan	27	1.2k 1.0×	844 0.8×	1.5k 1.6×	719 1.6×	199 0.5×	121	3.1k
Changping Wu China	28	1.2k 0.9×	820 0.7×	1.6k 1.6×	1.0k 2.4×	456 1.2×	78	3.3k
Taishi Hata Japan	30	1.1k 0.9×	826 0.7×	1.2k 1.2×	193 0.4×	783 2.1×	222	3.0k
Hanbyoul Cho South Korea	26	1.2k 0.9×	598 0.5×	1.1k 1.1×	504 1.2×	281 0.7×	94	2.7k
Jin Gu China	30	1.1k 0.8×	665 0.6×	1.5k 1.5×	285 0.7×	652 1.7×	154	3.0k

Countries citing papers authored by Thomas Bachleitner‐Hofmann

Since Specialization

Citations

This map shows the geographic impact of Thomas Bachleitner‐Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bachleitner‐Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bachleitner‐Hofmann more than expected).

Fields of papers citing papers by Thomas Bachleitner‐Hofmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bachleitner‐Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bachleitner‐Hofmann. The network helps show where Thomas Bachleitner‐Hofmann may publish in the future.

Co-authorship network of co-authors of Thomas Bachleitner‐Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Bachleitner‐Hofmann. A scholar is included among the top collaborators of Thomas Bachleitner‐Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Bachleitner‐Hofmann. Thomas Bachleitner‐Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Müller, Catharina, Michael Bergmann, Anton Stift, Thomas Bachleitner‐Hofmann, & Stefan Riss. (2024). Surgical and oncological outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma. Wiener klinische Wochenschrift. 137(7-8). 237–243.

Thaler, Josef, Thomas Bachleitner‐Hofmann, Holger Rumpold, et al.. (2024). Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis. Frontiers in Oncology. 14. 1374592–1374592. 2 indexed citations

Müller, Catharina, et al.. (2023). Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). SHILAP Revista de lepidopterología. 8(3). 113–121. 3 indexed citations

Müller, Catharina, Cristiano Ramos, Monika Sachet, et al.. (2022). Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression. Cancer Letters. 540. 215737–215737. 17 indexed citations

Pulverer, Walter, et al.. (2021). Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value. Current Issues in Molecular Biology. 43(3). 1419–1435. 18 indexed citations

Hametner, Christoph, et al.. (2021). Estimation of exogenous drivers to predict COVID-19 pandemic using a method from nonlinear control theory. Nonlinear Dynamics. 106(1). 1111–1125. 7 indexed citations

Unger, Lukas, Stefan Riss, Michael Bergmann, et al.. (2019). Outcome of no oral antibiotic prophylaxis and bowel preparation in Crohn’s diseases surgery. Wiener klinische Wochenschrift. 131(5-6). 113–119. 1 indexed citations

Schwameis, Richard, Anton Stift, Thomas Bachleitner‐Hofmann, et al.. (2018). Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 28(9). 1664–1671. 29 indexed citations

Riss, Stefan, Faheez Mohamed, Sanjeev Dayal, et al.. (2013). Peritoneal metastases from colorectal cancer: Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. European Journal of Surgical Oncology. 39(9). 931–937. 34 indexed citations

10.

Schauer, Dominic, Patrick Starlinger, Christian Reiter, et al.. (2012). Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer. PLoS ONE. 7(9). e44450–e44450. 37 indexed citations

11.

Bachleitner‐Hofmann, Thomas, Mark Y. Sun, Chin‐Tung Chen, et al.. (2011). Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET -Amplified Tumor Cells with or without Resistance to Selective MET Inhibition. Clinical Cancer Research. 17(1). 122–133. 33 indexed citations

12.

Blaha, Peter, Ruth Exner, Andrea Borgo, et al.. (2009). Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio. Breast Care. 4(3). 155–161. 2 indexed citations

13.

Blaha, Peter, Peter Dubsky, Florian Fitzal, et al.. (2009). Breast cancer chemoprevention - a vision not yet realized. European Journal of Cancer Care. 18(5). 438–446. 10 indexed citations

14.

Hayden, Hubert, Josef Friedl, Markus Dettke, et al.. (2009). Cryopreservation of Monocytes Is Superior to Cryopreservation of Immature or Semi-mature Dendritic Cells for Dendritic Cell-based Immunotherapy. Journal of Immunotherapy. 32(6). 638–654. 15 indexed citations

15.

Kandioler, Daniela, Georgios Stamatis, Wilfried Eberhardt, et al.. (2008). Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 135(5). 1036–1041. 36 indexed citations

16.

Dubsky, Peter, Hubert Hayden, Monika Sachet, et al.. (2007). Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture. Cancer Immunology Immunotherapy. 57(6). 859–870. 5 indexed citations

17.

Fitzal, Florian, O Riedl, Wolfgang Draxler, et al.. (2007). Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients. Breast Cancer Research and Treatment. 103(1). 45–52. 16 indexed citations

18.

Roka, R., Margaretha Rudas, Susanne Taucher, et al.. (2004). High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS. European Journal of Surgical Oncology. 30(3). 243–247. 37 indexed citations

19.

Bachleitner‐Hofmann, Thomas, et al.. (2003). Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients. Thrombosis Research. 112(4). 229–232. 11 indexed citations

20.

Taucher, Susanne, Margaretha Rudas, Michael Gnant, et al.. (2003). Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy.. Endocrine Related Cancer. 10(1). 91–98. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact